TD Cowen Maintains Hold on Novavax, Raises Price Target to $9

Benzinga Newsdesk www.benzinga.com Positive 78.3%

Neg 0% Neu 0% Pos 78.3%

TD Cowen analyst Chris LoBianco maintains Novavax (NASDAQ:NVAX) with a Hold and raises the price target from $8 to $9.

Comments

No comments yet. Be the first!